BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18481957)

  • 41. Tissue-specific alternative splicing of TCF7L2.
    Prokunina-Olsson L; Welch C; Hansson O; Adhikari N; Scott LJ; Usher N; Tong M; Sprau A; Swift A; Bonnycastle LL; Erdos MR; He Z; Saxena R; Harmon B; Kotova O; Hoffman EP; Altshuler D; Groop L; Boehnke M; Collins FS; Hall JL
    Hum Mol Genet; 2009 Oct; 18(20):3795-804. PubMed ID: 19602480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The rs7903146 Variant in the
    Cropano C; Santoro N; Groop L; Dalla Man C; Cobelli C; Galderisi A; Kursawe R; Pierpont B; Goffredo M; Caprio S
    Diabetes Care; 2017 Aug; 40(8):1082-1089. PubMed ID: 28611053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TCF7L2 Genotype and α-Cell Function in Humans Without Diabetes.
    Shah M; Varghese RT; Miles JM; Piccinini F; Dalla Man C; Cobelli C; Bailey KR; Rizza RA; Vella A
    Diabetes; 2016 Feb; 65(2):371-80. PubMed ID: 26525881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variants of the TCF7L2 gene are associated with beta cell dysfunction and confer an increased risk of type 2 diabetes mellitus in the ULSAM cohort of Swedish elderly men.
    Dahlgren A; Zethelius B; Jensevik K; Syvänen AC; Berne C
    Diabetologia; 2007 Sep; 50(9):1852. PubMed ID: 17618413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chikusetsu saponin IVa protects pancreatic β cell against intermittent high glucose-induced injury by activating Wnt/β-catenin/TCF7L2 pathway.
    Cui J; Duan J; Chu J; Guo C; Xi M; Li Y; Weng Y; Wei G; Yin Y; Wen A; Qiao B
    Aging (Albany NY); 2020 Jan; 12(2):1591-1609. PubMed ID: 31969494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stromal cell-derived factor-1 promotes survival of pancreatic beta cells by the stabilisation of beta-catenin and activation of transcription factor 7-like 2 (TCF7L2).
    Liu Z; Habener JF
    Diabetologia; 2009 Aug; 52(8):1589-98. PubMed ID: 19468708
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.
    Lyssenko V
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):385-92. PubMed ID: 18541996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcription factor TCF7L2 genetic study in the French population: expression in human beta-cells and adipose tissue and strong association with type 2 diabetes.
    Cauchi S; Meyre D; Dina C; Choquet H; Samson C; Gallina S; Balkau B; Charpentier G; Pattou F; Stetsyuk V; Scharfmann R; Staels B; Frühbeck G; Froguel P
    Diabetes; 2006 Oct; 55(10):2903-8. PubMed ID: 17003360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
    Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
    Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of variants of the TCF7L2 gene with increases in the risk of type 2 diabetes and the proinsulin:insulin ratio in the Spanish population.
    González-Sánchez JL; Martínez-Larrad MT; Zabena C; Pérez-Barba M; Serrano-Ríos M
    Diabetologia; 2008 Nov; 51(11):1993-7. PubMed ID: 18712344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An alternative polyadenylation signal in TCF7L2 generates isoforms that inhibit T cell factor/lymphoid-enhancer factor (TCF/LEF)-dependent target genes.
    Locke JM; Da Silva Xavier G; Rutter GA; Harries LW
    Diabetologia; 2011 Dec; 54(12):3078-82. PubMed ID: 21913056
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neonatal growth and regeneration of beta-cells are regulated by the Wnt/beta-catenin signaling in normal and diabetic rats.
    Figeac F; Uzan B; Faro M; Chelali N; Portha B; Movassat J
    Am J Physiol Endocrinol Metab; 2010 Feb; 298(2):E245-56. PubMed ID: 19920216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variants of the transcription factor 7-like 2 gene (TCF7L2) are strongly associated with type 2 diabetes but not with the metabolic syndrome in the MONICA/KORA surveys.
    Marzi C; Huth C; Kolz M; Grallert H; Meisinger C; Wichmann HE; Rathmann W; Herder C; Illig T
    Horm Metab Res; 2007 Jan; 39(1):46-52. PubMed ID: 17226113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1.
    Smushkin G; Sathananthan M; Sathananthan A; Dalla Man C; Micheletto F; Zinsmeister AR; Cobelli C; Vella A
    Diabetes; 2012 May; 61(5):1082-9. PubMed ID: 22461567
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H; Nagelkerke N; Carruthers SG; Benedict S; Abdulkhalek S; Reed R; Lukic M; Nicholls MG
    Diabetes Res Clin Pract; 2008 Jun; 80(3):392-8. PubMed ID: 18282631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype and tissue-specific effects on alternative splicing of the transcription factor 7-like 2 gene in humans.
    Mondal AK; Das SK; Baldini G; Chu WS; Sharma NK; Hackney OG; Zhao J; Grant SF; Elbein SC
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1450-7. PubMed ID: 20097709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program.
    Florez JC; Jablonski KA; Bayley N; Pollin TI; de Bakker PI; Shuldiner AR; Knowler WC; Nathan DM; Altshuler D;
    N Engl J Med; 2006 Jul; 355(3):241-50. PubMed ID: 16855264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-205 is up-regulated in islets of diabetes-susceptible mice and targets the diabetes gene Tcf7l2.
    Ouni M; Gottmann P; Westholm E; Schwerbel K; Jähnert M; Stadion M; Rittig K; Vogel H; Schürmann A
    Acta Physiol (Oxf); 2021 Aug; 232(4):e13693. PubMed ID: 34028994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SCRT1 is a novel beta cell transcription factor with insulin regulatory properties.
    Chriett S; Lindqvist A; Shcherbina L; Edlund A; Abels M; Asplund O; Martínez López JA; Ottosson-Laakso E; Hatem G; Prasad RB; Groop L; Eliasson L; Hansson O; Wierup N
    Mol Cell Endocrinol; 2021 Feb; 521():111107. PubMed ID: 33309639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.